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1	 This	text	develops	and	broadens	reflections	of	the	master’s	degree	dissertation	of	Georgia	Martins	Carvalho	Pereira,	defended	in	March	
of	2017	with	a	scholarship	of	the	Coordination	of	Improvement	of	Higher	Education	Personnel	(Capes),	under	the	direction	of	Rogerio	
Lopes	Azize.	A	first	outline	of	the	ideas	developed	here	was	presented	at	the	13th	World	Congress	of	Women	/	International	‘Doing	
Gender’	Seminar	11,	in	June	2017.
Abstract
Since	 the	 late	 1960s,	 attempts	have	been	made	
to	produce	a	 reversible	male	 contraceptive	with	
efficacy	equivalent	to	that	of	the	contraceptive	pill.	
To	date,	this	product	has	not	been	launched	and	the	
justifications	for	this	are	based	on	political,	economic,	
cultural	and	biological	barriers.	The	argument	of	
a	physiological	obstacle	has	a	 lot	of	prominence	
in	these	explanations	and	will	be	our	focus	in	this	
article.	From	the	perspective	of	gender	and	science	
studies,	we	aim	to	understand	how	this	argument	
appears	in	current	efforts	to	promote	this	technology	
by	a	prominent	actor	in	the	field,	the	US	NGO	Male	
Contraception	Initiative	(MCI).	By	using	the	document	
analysis	technique	and	the	methodology	of	discourse	
analysis,	we	aim	to	understand	how	the	male	body	is	
represented	and,	thus,	how	it	is	materialized	in	this	
process	of	developing	a	“male	pill”,	and	to	discuss	
the	gendered	character	of	biomedical	conceptions	
and	interventions	in	the	field	of	contraception.	We	
observed	that	the	reproductive	function	of	cisgender	
men	is	constructed	as	complex	and,	 in	a	sense,	as	
resistant	 to	pharmacological	 interventions.	Such	
characterization	occurs	in	comparison	with	the	female	
cisgender	body,	which	is	seen	as	more	accessible	for	
contraception.	The	traditional	association	between	
women	and	reproduction	and	men	and	sex	is	easily	
recognized	in	these	perspectives.
Keywords:	 Contraception;	Male	 Contraceptive	
Devices;	Gender;	Body;	Technology.
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Resumo
Desde	 o	 final	 dos	 anos	 1960,	 há	 tentativas	
de	 produção	 de	 um	 contraceptivo	masculino	
reversível	 com	eficácia	 equivalente	 à	 da	 pílula	
anticoncepcional.	 Até	 hoje,	 esse	 produto	 não	
foi	 lançado,	e	as	 justificativas	para	 tal	baseiam-
se	 em	 entraves	 de	 ordem	política,	 econômica,	
cultural	 e	 biológica.	O	argumento	do	obstáculo	
fisiológico	 tem	bastante	 proeminência	 nessas	
explicações	e	será	o	nosso	foco	neste	artigo.	Com	
base	nos	estudos	de	gênero	e	 ciência,	buscamos	
compreender	 como	 esse	 raciocínio	 aparece	 no	
trabalho	 de	 viabilização	 dessa	 tecnologia	 por	
um	ator	 de	 destaque	no	 campo,	 a	 organização	
não	 governamental	 (ONG)	 estadunidense	Male	
Contraception	Initiative.	Por	meio	da	técnica	de	
análise	de	documentos	e	com	base	na	metodologia	
de	 análise	do	discurso,	 buscamos	 compreender	
como	 o	 corpo	 masculino	 é	 representado	 e,	
consequentemente,	materializado	nesse	processo	
de	 viabilização	 de	 uma	 “pílula	masculina”,	 e	
debater	o	 caráter	generificado	das	concepções	e	
intervenções	biomédicas.	Observa-se	que	a	função	
reprodutiva	dos	homens	cisgêneros	é	construída	
como	complexa	e,	em	certo	sentido,	 resistente	a	
intervenções	 farmacológicas.	Tal	 caracterização	
se	 dá	 em	 comparação	 com	 o	 corpo	 feminino	
cisgênero,	que	é	configurado	como	mais	acessível	
para	a	realização	da	contracepção.	A	tradicional	
associação	entre	mulheres	e	reprodução	e	homens	e	
sexo	é	facilmente	reconhecida	nessas	perspectivas.
Palavras-chave:	 Anticoncepção;	 Dispositivos	
Anticoncepcionais	 Masculinos;	 Gênero;	 Corpo;	
Tecnologia.
2	 A	number	of	contraceptive	technologies	are	currently	being	developed	for	men	and	many	of	them	are	not	in	pill	form.	We	used	this	
expression,	imprecise	in	a	certain	sense,	due	to	its	circulation	in	the	field	analyzed.	Several	reports	dealing	specifically	with	other	
methods,	even	when	not	in	pill	form,	use	this	term,	demonstrating	its	symbolic	value	in	the	field	of	contraception	due	to	the	history	
and	impact	of	the	female	birth	control	pill.	The	use	of	quotation	marks	is	just	to	indicate	that	not	all	cases	involve	a	pill.
Introduction
Why	 is	 there	 no	 reversible	 contraceptive	
available	for	men	to	date	with	the	efficacy	of	the	
oral	 contraceptive	pill?	This	question	has	been	
answered	 in	a	number	of	ways,	but	 the	answers	
have	one	conclusion	in	common:	the	“male	pill”2 is 
a	difficult	 technology,	whether	 for	physiological,	
economic	and/or	cultural	reasons.	Recent	reports	
in	mass-media	vehicles	point	in	this	direction:
A	pill,	or	any	oral	treatment	for	men,	is	very	unlikely,	
because	 the	 testicles	produce	a	huge	amount	of	
sperm	per	day.	Therefore,	halting	this	production	
demands	 a	 very	 strict	 treatment,	with	many	
unwanted	side	effects.	(Por	que…,	2015)
The	 female	 pill	 uses	 hormones	 to	 block	 the	
production	of	one	egg	per	month.	The	production	
of	sperm	is	much	higher,	which	makes	a	male	pill	
somewhat	more	complex.	(Fábio,	2016)
Money	 is	 often	 the	guiding	word	 for	 decision	
making	 in	all	 industries.	The	cost	of	developing	
new	drugs	reaches	hundreds	of	millions	of	dollars,	
and	 in	 the	 case	 of	 a	male contraceptive pill,	
pharmaceuticals	find	the	market	insufficient,	they	
do	not	believe	men	would	opt	for	the	pill.	(Moraes,	
2017,	emphasis	added)
Since	 the	 late	 1960s,	 scientists	 around	 the	
world	have	been	conducting	research	to	make	this	
product	available,	but	to	this	day,	almost	50	years	
later,	it	still	is	not	available	in	any	country.	Despite	
its	absence	at	pharmacy	counters	and	doctor’s	or	
reproductive	planning	offices,	 the	 “male	pill”	 is	
a	well-known	technology.	The	1970s	already	saw	
global	announcements	that	such	a	product	would	
be	on	the	market	in	a	short	time.	In	Brazil,	Josilene	
da	Silva	(2004)	informs	that	one	of	the	first	news	
on	the	subject	was	published	in	1970	in	Jornal do 
Brasil.	Until	 then,	no	other	product	had	so	much	
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promotion	before	 being	 released	 for	 purchase	
(Oudshoorn,	2003).
Nowadays,	we	are	witnessing	another	wave	of	
announcements	of	the	availability	of	this	new	(old)	
technology.	The	media	announce	the	development	of	
different	contraceptives	for	men	and	again	indicate	
that	 their	release	will	occur	 in	 the	coming	years,	
without	agreement	on	how	close	this	is.	Hormonal	
pills	similar	to	the	female	oral	contraceptive	pill	are	
being	announced,	but	also	several	non-hormonal	
methods	focused	on	sperm	production,	maturation	
or	mobility,	as	well	as	mechanical	approaches	that	
focus	on	the	occlusion	of	the	vas	deferens	by	using	
some	device,	 similar	 to	 the	 idea	of	 a	 reversible	
vasectomy.
Based	 on	gender	 and	 science	 studies,	male	
contraceptives	 in	 development	 interest	 us	 as	
“gender-making”	objects,	 in	 the	sense	 that	 they	
produce	sexed	bodies.	As	Oudshoorn	(2003)	points	
out,	technologies	are	conditioned	by	gender	relations	
at	the	same	time	and	to	the	same	extent	that	they	
condition	 them.	Thus,	we	argue	 that,	 even	 if	we	
could	not	find	in	the	next	few	years	a	“male	pill”	for	
purchase,	the	efforts	to	develop	these	technologies	
have	symbolic	and	discursive	effects	that	deserve	
our	 attention.	The	discourses	 and	practices	 of	
the	actors	 involved	directly	or	 indirectly	 in	 their	
development	 involve	 the	 relationships	between	
men	and	women,	 their	bodies	and	 the	meanings	
they	 impart,	 for	example,	 to	notions	of	 risk	and	
safety,	reproduction,	contraception,	contraceptive	
responsibility,	reproductive	rights	and	paternity.
From	this	perspective,	this	line	of	physiological	
reasoning	regarding	male	contraception	seem	to	us	
an	interesting	object	of	analysis	to	reflect	on	how	
the	bodies	of	men	and	women	are	conceived	and	
accessed	by	biomedicine.	As	previously	noted,	media	
reports	state	that	there	is	yet	no	“male	pill”,	among	
other	factors,	because	men’s	bodies	make	fertility	
interventions	complex,	contrary	to	women’s	bodies,	
which	would	not	be.	This	article	aims	to	present	how	
3	 Founded	in	September	2013,	the	Consortium	aims	to	create	an	international	network	focused	on	the	promotion	of	contraceptives	for	men.	
It	is	currently	under	the	auspices	of	five	institutions:	European	Society	of	Contraception	and	Reproductive	Health,	Male	Contraception	
Initiative	(MCI),	Population	Council,	European	Society	of	Endocrinology	and	Société	Francophone	de	Contraception.
4	 MALE	CONTRACEPTION	INITIATIVE.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	on:	8	July,	2018.
5	 MALE	CONTRACEPTION	INITIATIVE.	Facebook:	@malecontraceptive.	Available	at:	<https://bit.ly/2U0AxX8>.	Accessed	on:	8	July,	2018.
6	MALE	CONTRACEPTION	INITIATIVE.	YouTube.	Available	at:	<https://bit.ly/2I12xsc>.	Accessed	on:	8	July,	2018.
this	physiological	justification	for	the	difficulty	of	
developing	the	product	appears	in	the	operation	of	a	
prominent	player	in	the	area	of		male	contraception,	
the	US	non-governmental	organization	(NGO)	Male	
Contraception	Initiative	(MCI).
Founded	in	2014	in	North	Carolina,	MCI	promotes	
male	contraception	by	fostering	the	development	
of	non-hormonal	 contraceptive	 technologies.	 In	
addition	to	engaging	in	the	production	of	certain	
male	 contraceptives	 by	 campaigning	 for	 its	
financing,	 the	organization	works	by	publicizing	
other	non-hormonal	 contraceptive	projects	 for	
men	and	seeks	to	raise	public	awareness	of	their	
importance	 and	need,	 developing	 actions	 and	
promotional	materials.	MCI	is	one	of	five	institutions	
composing	 the	 International	 Consortium	 for	
Male	Contraception3	 and,	 together	with	 other	
organizations	and	scientists,	 is	one	of	 the	main	
sources	of	national	and	international	newspapers	
and	magazines	on	the	subject.
To	 analyze	how	 the	physiological	 difficulty	
justification	appears	in	the	operation	of	this	entity,	
we	used	the	technique	of	document	analysis	based	
on	a	socio-anthropological	approach.	We	selected	
texts	published	on	the	organization’s	website4,	on	
its	Facebook	page5	and	videos	posted	on	YouTube6,	
as	well	as	media	written	reports	that	mention	MCI	
or	are	authored	by	one	of	its	members.
We	did	a	discourse	analysis	of	 the	 texts	and	
videos,	 a	method	 that	 seeks	 to	understand	 the	
association	 between	 oral,	 textual	 or	 imagery	
communication	and	its	social,	political,	historical	
and	cultural	dimension.	Discourses	are	viewed,	
from	a	Foucaultian	perspective,	as	inseparable	from	
relations	of	power,	practices	and	institutions;	they	
are	seen	not	only	as	representative	of	or	mirrors	that	
reflect	social	organization,	but	also	as	producers	of	
social	reality.	This	methodology	mainly	focuses	the	
production	and	reception	of	discourses	and	their	
relation	 to	 the	 reproduction	of	 social	 relations,	
ideologies	and	hegemonies	(Lupton,	1992).
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MCI	website’s	blog	contains	the	largest	number	
of	documents.	Since	September	2014,	there	has	been	
at	least	one	new	text	per	month,	totaling	34	until	
December	2016.	We	 focused	 these	publications	
because	 they	 are	 the	NGO’s	main	medium	 for	
presenting	 its	 arguments	and	debates	on	male	
contraception.	MCI’s	Facebook	page	was	created	
in	September	 2014,	 and	 395	publications	have	
been	posted	as	of	January	2,	2017.	At	that	time,	only	
MCI’s	publications	were	posted;	the	public	had	their	
participation	restricted	 to	commenting	on	 those	
posts.	 In	general,	posts	 included	 links	to	articles	
on	male	 contraception	published	by	 the	media,	
with	emphasis	on	texts	mentioning	the	NGO	or	its	
members,	in	addition	to	the	monthly	information	
on	the	activities	carried	out	by	 the	organization.	
Due	 to	 the	 large	volume	of	material,	we	selected	
publications	posted	only	in	2016,	between	January	
and	July,	totaling	76	analyzed	posts.	On	YouTube,	
in	turn,	were	uploaded,	as	of	January	2017,	10	short	
organizational	videos,	usually	between	one	and	
four	minutes	long;	all	were	included	in	the	analysis.
The physiological-dif f icul ty 
justification in the field of male 
contraception
The	 supposed	 existence	 of	 a	 physiological	
impediment	 to	masculine	 contraception	 is	not	
something	new	 in	 the	field.	Nelly	Oudshoorn	 in	
her	 biography	 of	 the	 “male	 pill”	 (2003),	which	
encompasses	 several	 attempts	 to	 develop	 this	
technology	between	 the	 late	 1960s	and	 the	 late	
1990s,	points	out	that	the	difficulty	of	suppressing	
sperm	production	in	a	reversible	manner	and	the	
side	effects	 involved	–	 that	 is,	aspects	related	 to	
body	functioning	–	were	traditionally	identified	as	
obstacles	to	the	launching	of	this	product,	both	in	
scientific	and	 lay	environments.	The	aim	of	 this	
author	 is	precisely	 to	overcome	such	essentialist	
explanations,	which	indicate	the	body	of	cisgender	
men7	 as	 the	 reason	 for	 the	 gender	 asymmetry	
embodied	in	contraceptive	technologies.
7	 In	this	article,	we	will	deal	with	biomedical	conceptions	of	cisgender	bodies	–	thus,	references	to	men	and	women	specifically	address	
cis	bodies.
As	for	the	identified	complexity	of	intervening	in	
the	spermatogenesis,	Oudshoorn	(2003)	states	that	
scientists	disagree	about	whether	it	is	more	difficult	
then	 suppressing	 egg	production.	While	 some	
experts	point	out	the	difference	between	male	and	
female	bodies,	arguing	that	targeting	the	continuous	
production	of	“billions”	of	spermatozoa	is	far	more	
tricky	than	targeting	the	production	of	“just”	one	
egg	per	month,	others	argue	 that	 the	amount	of	
gametes	produced	is	not	relevant,	focusing	on	the	
similarities	of	the	mechanisms	in	men	and	women	
and	highlighting	the	similitude	of	the	reproductive	
systems’	hormonal	regulation.	Some	argue	that	it	
is	easier	to	suppress	sperm	production	because	it	
is	a	continuous	process,	whereas	egg	production	
is	discontinuous.	The	author	points	out	 that	 this	
controversy	in	the	field	illustrates	the	flexibility	of	
interpretations	of	biological	facts,	since	the	same	
phenomenon	can	be	understood	as	a	facilitator	or	
a	barrier	to	interfere	in	human	bodies.
As	for	the	side	effects,	Oudshoorn	(2003)	points	
out	that	these	are,	in	many	cases,	similar	to	those	
caused	by	the	female	contraceptive	pills	–	that	is,	
in	 the	 case	of	women’s	bodies,	 such	effects	did	
not	 represent	an	 impediment,	making	clear	 that	
notions	such	as	safety	and	risk	are	associated	with	
the	gender	of	individuals.	Josilene	da	Silva	(2004),	
in	her	analysis	of	national	press	material	 in	 the	
1970s	and	 1980s	on	male	contraceptives,	 shows	
that	in	these	reports	side	effects	were	the	central	
justification	presented	to	the	general	public	for	the	
nonexistence	of	oral	contraceptives	for	men.	In	the	
period	studied,	national	newspapers	pointed	to	side	
effects	similar	to	those	of	the	female	contraceptive	
pill	as	obstacles	to	the	availability	of	the	product,	
emphasizing	that	men	would	not	be	willing	to	face	
the	same	inconveniences	as	women,	as	is	clear	in	
this	segment,	cited	by	the	author:
Contraceptive	pills	for	men	have	not	reached	the	
public	because	they	cause	side	effects	that	have	not	
been	eliminated	as	yet.	[…]	Fattening	4	or	5	kg	for	
a	year	for	those	who	would	take	the	pill	for	many	
years	is	something	that	women	can	agree	on,	but	
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not	men.	(Jornal	de	Santa	Catarina,	1978,	page	5,	
cited	by	Silva,	2004,	p.161)
Several 	 projects	 aimed	 at 	 developing	
contraceptives	 for	men,	 especially	 hormonal	
contraceptives,	were	 suspended	because	of	 the	
side	effects	of	 the	 technologies	 tested.	Although	
the	results	of	many	of	these	studies	with	hormonal	
methods	were	considered	effective,	 the	 issue	of	
safety	and	side	effects	appeared	to	be	an	impediment	
to	the	advancement	of	testing.
Risk	assessment	of	contraceptives	seems	to	give	
more	weight	 to	side	effects	when	related	to	male	
use,	with	emphasis	on	interferences	in	sexuality,	
which	has	become	 the	effects	most	debated	and	
highlighted.	Since	 the	 first	male	 contraceptive	
researches	conducted	in	the	United	States	in	the	late	
1950s,	there	has	been	a	growing	concern	about	male	
sexuality,	the	production	of	seminal	fluid	and	loss	
of	libido	and	erection	difficulties.	Although	there	
have	been	reports	of	loss	of	sexual	desire	by	women	
since	the	introduction	of	the	contraceptive	pill,	it	
was	only	in	the	1990s	that	researchers	focused	on	
their	impact	on	sexuality.	However,	this	was	not	the	
only	difference,	since	risk	tolerance	regarding	men’s	
bodies	was	much	lower	overall	(Oudshoorn,	2003).
Taking	 into	account	 this	differentiated	and	
gender-related	 risk	 concept	 let	us	now	 turn	 to	
how	these	 issues	of	side	effects	and	difficulty	 in	
interfering	with	spermatogenesis	are	addressed	by	
MCI	in	its	promotion	of	non-hormonal	contraceptives	
for	men.	Our	focus	is	on	the	conceptions	that	this	
NGO	produces	and	reproduces	regarding	male	bodies,	
especially	regarding	their	reproductive	system.
Complex bodies for hormonal 
contraceptive interventions
MCI	views	reversible	male	contraceptives	as	viable	
and	necessary	technologies	that	are	not	available	in	
8	We	do	not	conceive	technique	and	physiology	as	separate	and	distinguishable	from	the	social	world;	these	dimensions	are	mutually	
conditioned,	and	there	is	no	precise	separation.	However,	we	use	the	terms	in	this	passage	according	to	the	conceptions	of	the	field	
analyzed,	more	specifically	the	non-governmental	organization	(NGO)	studied,	which	uses	these	terms	according	to	common	sense.
9	HANLIM,	A.	Better	birth	control	 for	men:	how	would	 it	work?	What’s	 in	 the	pipeline?	May	 17,	 2016.	Available	at:	 <https://www.
malecontraceptive.org>.	Accessed	on:	8	Mar,	2017.
10	HANLIM,	A.	International	consortium	on	male	contraception.	31	May	2016.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	on:	 
8	Mar,	2017.
the	market	due	to	various	social,	political,	cultural	
and	economic	issues;	it	also	recognizes,	accessorily,	
technical	and	physiological	difficulties8	 for	 the	
development	of	this	kind	of	contraceptive	product.
To	answer	the	question	that	opens	our	article	–	
“Why	do	we	still	have	no	reversible	contraceptive	
available	 for	men	with	 the	efficacy	of	 the	 female	
contraceptive	pill?”	–	MCI	does	not	put	biology	first,	
as	do	many	articles	published	in	the	media.	Lack	of	
funding	is	presented	as	the	major	problem	for	the	
development	of	these	technologies.
In	a	video	–	“Why did you become interested in 
male contraception?”	–	David	Sokal,	then	the	NGO’s	
president,	says	that	one	of	the	reasons	for	founding	
MCI	was	 the	shame	he	 felt	as	a	doctor	when	he	
realized	that	there	was	more	investment	in	animal	
contraception	 than	 in	male	 contraception	 (Why	
did	…,	2015).	The	high	cost	of	drug	development	is	
constantly	underscored	by	the	organization:
Getting	real	alternatives	 into	 the	hands	of	men	
who	want	them	won’t	be	easy	or	cheap.	[…]	The	male	
contraceptive	nearest	to	market	[…]	is	languishing	
in	clinical	trials	for	lack	of	research	funding.9
Research	is	expensive	and	there	is	a	need	for	funds	
to	make	progress	happen.10
MCI	 also	 emphasizes	 the	 omission	 of	 the	
pharmaceutical	 industry,	 reluctant	 to	 invest	 in	
innovations	in	the	field	of	contraception,	for	both	
men	and	women.	The	NGO	explains	that	research	
and	development	of	contraceptives	involves	high	
financial	 risk,	 complex	 regulations	 and	many	
years	 of	work,	 as	well	 as	high	 risk	 of	 lawsuits	
related	 to	 safety	 and	 efficacy,	 and	 is	 thus	not	
attractive	 to	 large	 pharmaceutical	 companies.	
In	the	case	of	technologies	for	men,	the	rejection	
of	 the	 industry	 is	 even	 greater,	 due	 to	 doubts	
regarding	consumer	interest.
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Physiological	considerations,	however,	are	not	
absent	from	the	NGO	discourse.	In	various	online	
media	texts	published	on	the	MCI	Facebook	page,	
the	amount	of	sperm	produced	daily	by	men’s	bodies	
is	presented	as	a	challenge	to	the	development	of	
reversible	male	contraceptives	when	compared	to	
the	production	of	one	egg	per	month	by	the	bodies	
of	women.
Finding	 a	male	 birth	 control	 option	 besides	
vasectomies	and	condoms	has	proved	difficult	
because	 men	 are	 capable	 of	 producing	 an	
astounding	1,500	sperm	cells	in	a	single	second.	
(Schubert,	2016)
The	 biology	 is	 the	 biggest	 hurdle	…	 at	 every	
heartbeat	men	 produce	 thousands	 of	 sperm	
(Senthilingam,	2016).
MCI	 does	 not	 deny	 this,	 but	 presents	 the	
physiological	impediment	as	a	problem	specifically	
related	to	hormonal	approaches.	In	a	video	–	“Why 
is making a male contraceptive so difficult?” – Sokal	
claims	 that	hormones	are	extremely	effective	 in	
controlling	pregnancy	–	but	he	points	out	that	there	
is	a	difference	between	female	and	male	bodies,	since	
it	 is	possible	 to	prevent	contraception	 in	women	
with	 low	doses,	whereas	 for	men	 it	would	 take	
high	hormonal	doses,	producing	many	side	effects	
(Why	 is	…,	2015).	Sokal	explains	 that	 the	ovaries	
stop	producing	eggs	during	pregnancy,	a	natural	
state	 that	could	be	mimicked	by	using	hormones	
to	simulate	a	gestation;	in	the	case	of	men,	there	
is	no	natural	state	in	which	there	is	no	production	
of	spermatozoa,	so	it	would	require	large	amounts	
of	hormones	 to	affect	male	gametes.	Explaining	
that	higher	hormone	levels	are	needed	to	interfere	
with	spermatogenesis,	 the	NGO	argues	 that	 the	
side	effects	of	hormonal	methods	in	men	would	be	
worse	than	the	effects	on	women	who	use	the	pill	or	
other	hormonal	methods.	MCI’s	comments	about	the	
suspension	in	2011	of	a	clinical	study	of	a	hormonal	
11		HANLIM,	A.	Male	contraception	begs	for	a	paradigm	shift.	Nov	28	2016.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	
on:	8	Mar,	2017.
12	HANLIM,	A.	Male	contraception	begs	for	a	paradigm	shift.	Nov	28	2016.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	
on:	8	Mar,	2017.
method	sponsored	by	the	World	Health	Organization	
go	in	this	direction:
To	be	 clear,	 every	drug	has	side	effects.	Those	
side	effects,	for	instance,	are	the	top	reasons	for	
discontinuation	for	both	Depo-Provera	and	the	Pill.	
While	sometimes	exasperating,	most	of	those	risks	
aren’t	actually	fatal.	Even	in	the	worst	case	scenario	
with	smokers	aged	35–44,	the	annual	attributable	
risk	of	death	for	those	using	oral	contraceptives	
is	less	than	one	in	5,000.	In	this	study,	however,	
there	was	an	actual	 suicide	 and	an	attempted	
suicide	within	a	sample	of	just	over	a	few	hundred	
in	only	a	year.	That’s	on	top	of	the	issues	already	
mentioned.	We	may	partly	be	seeing	these	more	
severe	side	effects	simply	because	it	takes	a	higher	
hormonal	dosage	to	stop	sperm	production	than	to	
stop	ovulation.11
There	are	constant	mentions	to	problems	related	
to	 the	use	 of	 hormones	 to	 interfere	with	male	
fertility.	In	a	blog	post	on	November	28,	2016,	the	
following	problems	are	listed:	severe	side	effects;	
delay	in	the	contraceptive	effectiveness;	need	for	
men	to	perform	repeated	sperm	counts;	presence	of	
nonresponders	–	i.e.	individuals	in	whom	hormones	
are	not	effective	for	contraception;	and	the	risk	that	
sperm	count	will	not	return	to	normal	levels	after	
discontinuation	of	the	use	of	the	drug	–	that	is,	no	
reversibility	of	the	method.12
Dangerous	side	effects,	a	recurring	theme	in	the	
field	of	contraception,	for	both	sexes,	are	brought	to	
the	fore	by	the	NGO	in	association	with	hormonal	
methods.	Non-hormonal	technologies	fostered	by	the	
institution	are	often	presented	as	safe,	potentially	
effective	and	without	worrying	side	effects.	It	is	also	
mentioned	that	studies	will	be	carried	out	to	solve	
side	effects	of	possible	contraceptive	drugs	that	are	
in	the	initial	phases	of	research.
Based	on	 these	 criticisms,	MCI	advocates	 a	
change	 in	 the	 field	 of	male	 contraceptives,	 so	
investments	and	efforts	will	focus	on	non-hormonal	
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methods	and	preferably	on	long-term	methods,	since	
they	present	lower	pregnancy	rates	because	they	do	
not	depend	directly	on	the	correct	administration	
by	the	user.
We	 could	 be	wrong,	 but	we	would	 feel	much	
better	 if	other	approaches	 for	developing	male	
contraceptives were	getting	as	much	attention	
and	 funding	as	male	hormonal	methods	 –	 even	
though	there	are	more	unknowns	for	non-hormonal	
methods,	because	 they	are	at	 earlier	 stages	of	
research”.	received	as	much	attention	and	funding	
as	male	hormonal	methods	–	although	there	are	
more	unknowns	to	non-hormonal	methods	because	
they	are	in	the	early	stages	of	research.13
It’s	time	to	focus	on	a	new	paradigm	–	non-hormonal	
male	contraceptives.14
MCI	uses	the	notion	of	physiological	difficulty	
to	explain	why	we	do	not	have	a	male	contraceptive	
available	 today,	but	circumscribes	 this	difficulty	
to	hormonal	 technologies,	 rather	 than	 the	non-
hormonal	technologies	it	promotes.	The	quantity	of	
gametes	produced	by	men’s	bodies	is	often	compared	
to	 the	quantity	produced	by	women’s	bodies	 to	
illustrate	the	ease	of	preventing	pregnancy	by	using	
hormones	in	their	case.
Sperm	production	begins	in	puberty	and	continues	
through	adulthood,	maintained	by	high	levels	of	
testosterone	within	the	testes.	The	entire	process	
takes	between	74	and	 120	days,	 and	 the	 testes	
produce	200	to	300	million	sperm	each	day.	That’s	
about	1000	sperm	for	every	heartbeat!	 (Think	of	
this	in	contrast	with	the	monthly	ovulation	cycle	
of	women	and	the	relative	ease	of	targeting	a	single	
egg	issued	by	a	woman	each	month	by	comparison.)15
Thus,	while	 female	bodies	 are	portrayed	as	
favorable	 to	 contraception,	male	 bodies	 are	
13	HANLIM,	A.	International	consortium	on	male	contraception.	31	May	2016.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	on:	
8	Mar,	2017.
14	HANLIM,	A.	Male	contraception	begs	for	a	paradigm	shift.	Nov	28	2016.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	on:	
8	Mar,	2017.
15	HANLIM,	A.	10	myths	on	male	contraception	debunked.	Nov	29	2015.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	on:	
8	Mar,	2017.
treated	as	inconvenient	to	hormonal	contraceptive	
interventions.	 It	 is	 interesting	 to	 note	 that,	
regarding	sexuality,	we	observe	exactly	the	opposite.	
Historically,	sexuality	seems	to	have	been	one	of	the	
main	focuses	for	transforming	men	into	patients	
(Rohden,	2012).	This	tendency	seems	to	remain	in	
place,	since	the	extent	of	(bio)medicalization	of	men	
in	the	last	decades	of	the	twentieth	century	and	at	the	
beginning	of	the	twenty-first	century	is	marked	by	an	
emphasis	on	sexuality	reduced	to	the	sexual	organ	
(Azize,	2011;	Rohden,	2009,	2012).	Female	sexuality,	
on	the	contrary,	is	conceived	as	encompassing	the	
whole	body	of	the	woman,	being	more	diffuse	and	
complex	(Tramontano;	Russo,	2015).
Russo	et	al.	(2011)	show	how	this	perspective	was	
illustrated	in	sexology	congresses	by	the	image	of	an	
airplane	panel	full	of	buttons	representing	female	
sexuality,	while	male	sexuality	was	 represented	
by	a	single	button,	in	the	simple	form	of	an	on/off	
power	switch.	This	last	idea	was	precisely	the	image	
used,	now	in	the	opposite	direction,	to	characterize	
the	ease	of	interrupting	egg	production	in	women’s	
bodies	and	ensuring	contraception.	 It	 appeared	
in	Tiven’s	 text	 (2016),	 shared	on	MCI’s	Facebook	
page	on	July	25,	2016:	“It	only	takes	small	doses	of	
hormones	to	flip	the	‘on-off	switch’	in	women	that	
stops	the	ovaries	from	producing	eggs.”
Tramontano	 (2017)	gives	another	example	of	
the	materialization	of	 this	conception	of	 female	
sexuality	 as	 something	 complex.	By	analyzing	
science	manuals	used	 in	undergraduate	health	
courses	 in	Brazil,	 this	author	demonstrates	how	
gender	conceptions	materialize	in	the	differentiation	
between	hormones	 termed	masculine	and	 those	
termed	feminine.	The	author	points	out	how	one	
of	 these	manuals,	 through	 figures	 and	 texts,	
presents	 the	hormones	 considered	 feminine	as	
weaker	 and	 less	 objective	 than	 the	masculine,	
besides	emphasizing	 their	 role	 in	 reproduction.	
He	also	analyzes	figures	comparing	the	functions	
of	testosterone	with	those	of	estradiol,	concluding	
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that	“the	idea	of		female	sexuality	as	diffuse,	fluid,	
unstable,	less	visible,	less	potent	and	more	amenable	
to	reproduction	is	reiterated,	even	if	unintentionally”	
(Tramontano,	2017,	p.185).
Pharmacological	 treatments	 for	 the	so-called	
sexual	dysfunctions	also	demarcate	this	asymmetry	
between	conceptions	of	male	and	female	sexuality.	
Viagra	and	other	pro-sexual	drugs	aimed	at	men	
act	by	 facilitating	 the	maintenance	of	 erection,	
materializing	 a	male	 sexuality	 focused	on	 the	
penis.	Mainly	due	to	the	success	and	diffusion	of	
these	drugs,	 there	were	attempts	 to	 extend	 the	
physiological	anatomical	model	focused	on	the	male	
genitalia	to	female	sexuality.	Tests	carried	out	with	
Viagra	on	women	have	realized	this	project.	Due	to	
the	failure	of	these	studies,	 the	focus	of	the	 (bio)
medicalization	of	 female	sexuality	 fell	on	desire	
(Rohden,	2009).	The	drug	flibanserin,	released	as	
the	“female	Viagra”	and	approved	 in	2015	by	 the	
Food	and	Drug	Administration,	acts	on	the	central	
nervous	system,	thus	reinforcing	the	idea	of		women’s	
sexuality	as	something	more	complex	and	diffuse.
It	is	thus	possible	to	draw	an	interesting	parallel:	
while	 the	 female	body	 is	 conceived	as	 complex	
in	 relation	 to	 pharmacological	 interventions	
in	 sexuality,	 the	masculine	 is	 constructed	 as	
complex	in	relation	to	reproductive	interventions.	
Conversely,	the	female	body	seems	quite	accessible,	
at	least	since	the	1960s,	to	contraceptive	hormonal	
interventions,	while	male	bodies	seem	to	have	had	
their	sexual/erectile	biology	unraveled	by	the	“Viagra	
phenomenon.”	 In	other	words,	 the	naturalization	
of	the	relationship	between	contraception	and	the	
female	body	has	a	scientific	expression,	which	in	turn	
enhances	the	relationship	itself.	The	same	is	true	of	
the	relationship	between	men	and	their	supposedly	
more	sexual	nature,	which	was	“discovered”	to	be	
based	on	a	purely	mechanical	relationship,	taking	
us	back	to	the	starting	point.	These	techniques,	their	
metaphors	and	 their	 representations	are	always	
fraught	with	 our	 broader	 cultural	 conceptions	
regarding	gender	and	sexuality.
The	 traditional	 association	between	women	
and	reproduction	and	between	men	and	sex	–	as	
if	 the	 former	were	made	for	motherhood	and	the	
latter	 for	sex	 (Oliveira;	Bilac;	Muszkat,	2011)	 –	 is	
easily	recognized	in	these	biomedical	perspectives.	
The	complexity	associated	with	 interventions	 in	
male	 reproduction	 is	 (re)produced	by	MCI	when	
it	explains	the	lack	of	a	male	contraceptive	based	
on	the	difficulty	of	controlling	sperm	production	
through	hormones.
It	is	necessary	to	emphasize	that	the	strength	
of	 the	 woman-reproduction	 versus	man-sex	
associations	goes	beyond	the	biomedical	sciences	
and	their	 technologies	and	can	also	be	 identified	
in	 social	 sciences’	 studies	 on	 sexuality	 and	
reproduction.	Fonseca	(2004,	p.16)	points	out	that	the	
earliest	masculinity	studies	focused	mainly	on	non-
reproductive	sexuality	in	their	approach	to	men,	and	
thus	“in	the	absence	of	any	mention	of	reproduction,	
this	remained	a	subject	almost	exclusively	female.	
(Sexuality	was	 for	men	as	 reproduction	was	 for	
women	–	‘natural’).”
We	 can	 thus	 say	 that	 the	 approach	 to	 the	
male	body	became,	at	 least	at	first,	the	model	for	
pharmacological	interventions	in	female	sexuality;	
while	 the	approach	to	 the	 female	body,	primarily	
hormonal,	has	become,	in	the	same	sense,	the	model	
for	contraceptive	 interventions	 in	 the	male	body.	
On	 the	other	hand,	 it	 is	 interesting	 to	note	 that	
such	models,	when	transposed	to	the	opposite	sex,	
find	resistance.	Although	still	widespread,	both	the	
“Viagra	model”	for	interventions	in	female	sexuality	
and	the	“hormonal	model”	for	contraception	in	male	
bodies	are	widely	criticized	and	often	turned	down	in	
favor	of	other	approaches;	see,	for	example,	the	New	
View	of	Women’s	Sexual	Problems	campaign,	led	by	
Leonore	Tiefer,	which	opposes	the	medicalization	
of	 female	 sexuality	 (Rohden,	 2009),	 and	MCI’s	
criticisms	 of	 the	 hormonal	 paradigm	of	male	
contraception	and	 its	 support	 to	non-hormonal	
approaches	(Pereira,	2017).
The	development	 and	 launching	 of	 a	 “male	
pill,”	 a	 technology	 that	 could	 break	with	 the	
relative	 invisibility	of	 the	 reproductive	body	of	
men,	as	opposed	 to	 the	advancement	of	 the	 (bio)
medicalization	of	their	sexual	body,	has	precisely	
the	 complexity	of	 this	body	as	one	of	 the	main	
justifications	 for	 its	non-availability.	MCI	 (re)
produces	the	notion	of	the	male	reproductive	body	
as	resistant	to	hormonal	biomedical	interventions,	
but	argues	 that	advances	 in	biotechnology	have	
opened	up	and	would	open	up	new	perspectives.	
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It	is	with	this	argument	that	they	advocate	a	“new	
non-hormonal	paradigm”	 for	 the	development	of	
male	contraceptives.
We	are	not	advocating	here	a	hormonal	paradigm	
for	male	contraception	neither	disregarding	 the	
warnings	about	the	side	effects	of	using	hormones	
for	contraception	in	men	or	women.	However,	it	is	
worth	noting	that	the	refusal	to	use	contraceptive	
hormones	occurs	simultaneously	with	the	expansion	
of	its	use	in	the	treatment	of	androgen	deficiency	
in	the	aging	male	–	popularly	known	as	andropause	
–	 and	 in	 biomedical	 treatments	 –	 increase	 of	
muscle	 strength	 and	mass,	 improvement	 of	
sports	performance	and	of	 libido,	among	others	
(Hoberman,	 2005).	One	might	question	whether	
there	would	be	greater	tolerance	for	possible	side	
effects	of	hormonal	“treatments”	linked	to	sexuality,	
aesthetics	and	physical	performance	than	for	those	
arising	 from	contraception.	Would	contraceptive	
doses	necessarily	be	so	different	from	those	used	
for	widespread	treatments	and	enhancements?
In	MCI’s	explanations	regarding	the	physiological	
difficulty	to	interfere	with	male	gametes,	it	is	worth	
mentioning	the	emphasis,	almost	in	a	complimentary	
tone,	on	the	quantity	of	sperm	produced	by	men;	it	
is	inevitable	to	recall	Emily	Martin’s	(1991,	2006)	
analysis	 of	 how	gender	 conceptions	 permeate	
scientific	descriptions	of	male	and	female	bodies	
and	their	functioning.	In	the	article	“The egg and 
the sperm: how science has constructed a romance 
based on stereotypical male-female roles,”	this	author	
points	out	how	physiological	phenomena	 in	 the	
bodies	of	men	and	women	are	unequally	portrayed,	
both	 in	 scientific	and	 lay	 circles,	 and	based	on	
stereotypes	related	 to	our	cultural	definitions	of	
the	masculine	and	the	feminine.	By	analyzing	the	
description	of	sperm	and	eggs	in	scientific	texts,	she	
shows	that	the	female	gamete	is	characterized	as	
large	and	passive,	while	the	masculine	is	portrayed	
as	small,	aerodynamic	and	active.	The	verbs	used	
to	describe	 the	spermatozoa	 in	 the	 fertilization	
process	are	usually	in	the	active	voice	(“penetrates,”	
“crosses”),	whereas	 in	 the	 case	 of	 ovules,	 they	
appear	 in	 the	passive	voice	 (“is	penetrated,”	 “is	
transported”).	Differences	between	gametes	are	
emphasized,	and	sperm	and	eggs	are	configured	
with	 characteristics	 associated,	 respectively,	
to	masculinity	 and	 femininity.	Moreover,	 the	
phenomena	in	the	male	bodies	are	more	valued	and	
presented	as	more	meritorious,	mirroring	and,	in	a	
sense,	materializing	widespread	notions	about	men	
and	women	in	a	social	context	of	gender	inequality.	
Descriptions	of	 sperm	production	use	positive	
adjectives,	mainly	emphasizing	the	large	quantity	
of	these	cells	produced	by	the	men,	in	comparison	
to	the	smaller	production	of	eggs	by	women;	thus,	
male	bodies,	 in	 the	descriptions,	appear	as	more	
productive	 than	 female	 ones.	 Another	 central	
point	 raised	by	Martin	 is	precisely	 the	 fact	 that	
reproductive	systems,	both	male	and	 female,	are	
represented	by	metaphors	 related	 to	 industrial	
production,	being	portrayed	as	systems	that	produce	
valuable	substances.	In	fact,	the	author	points	out	
how	conceptions	of	 the	body	as	a	whole	relate	 to	
the	current	political-economic	system,	and	there	
are	many	manufacturing	metaphors,	among	others,	
in	 the	descriptions	of	physiological	phenomena	
(Martin,	1991,	2006).
Her	interest	lies	in	how	culture	shapes	the	way	
scientists	describe	what	 they	discover	about	 the	
“natural	world”;	she	points	out	that	the	“facts”	of	
biology	may	not	always	be	constructed	in	cultural	
terms,	but	she	argues	that	in	this	case	gametes	and	
the	process	of	 fertilization	are	shaped	by	gender	
conceptions.	 Thus,	 she	 says	 that	new	 findings	
regarding	the	fertilization	role	of	the	egg	did	not	
change	the	approach	to	gametes	or	conception,	not	
affecting	the	notion	of	the	egg	as	passive	and	the	
sperm	as	active.	That	is,	new	data	did	not	lead	to	
the	elimination	of	gender	stereotypes	in	scientific	
descriptions.
Although	this	new	version	of	the	saga	of	the	egg	
and	the	sperm	broke	through	cultural	expectations,	
the	researchers	who	made	the	discovery	continued	
to	write	papers	and	abstracts	as	if	the	sperm	were	
the	active	party	who	attacks,	binds,	penetrates,	and	
enters	the	egg.	The	only	difference	was	that	sperm	
were	now	seen	as	performing	these	actions	weakly.	
(Martin,	1991,	p.	493)
The	flexibility	of	biological	facts	interpretations	
emphasized	by	Oudshoorn	(2003)	is	also	addressed	
by	Martin	(1991),	who	warns	that	the	way	in	which	
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scientists	interpret	their	data	can	have	important	
social	effects.	 In	 the	case	of	gametes,	 she	states	
that	gender	stereotypes	are	inscribed	in	the	cellular	
constitution	of	organisms,	making	them	appear	so	
natural	as	to	not	be	amenable	to	change.
The	negative	way	 in	which	 the	 female	body	
and	its	functioning	are	interpreted	and	described	
is	emphasized	by	 the	author,	who	questions	 the	
celebration	 of	 sperm	production	 because	 it	 is	
continuously	produced	from	puberty	to	old	age,	while	
the	production	of	the	female	gamete	is,	in	a	sense,	
conceived	as	inferior,	since	it	ends	at	the	birth	of	
the	female	child.	This	phenomenon	is	interpreted	
by	portraying	the	female	body	as	unproductive,	but	
Martin	questions	why	the	vast	production	of	sperm	
is	not	seen	as	an	unsuccessful	production,	a	waste,	
as	menstruation	 is	 interpreted	 in	many	medical	
texts	(Martin,	1991,	2006).
The	way	MCI	describes	the	functioning	of	male	
contraceptive	technologies	in	men’s	bodies,	as	well	
as	the	way	it	explains	the	physiological	difficulty	
associated	with	the	complexity	of	controlling	the	
production	of	male	gametes	using	hormones,	is	an	
ethnographic	case	similar	to	Martin’s	observations	
(1991).	The	portrayal	of	sperm	as	an	active	ingredient,	
the	 emphasis	 on	 the	higher	quantity	 of	 sperm	
produced	by	men	in	relation	to	egg	production	by	
women,	and	 the	manufacturing	metaphors	are	a	
constant	in	the	material	analyzed.
Researchers	 say	 the	 final	burst	 of	 the	 sperm	
approaching	an	egg	is	a	key	to	boosting,	or	even	
suppressing,	male	fertility.	(Schneiderman,	2018,	
emphasis	added)	and	our	translation)
This	binding	inhibits	the	movement	of	the	sperm	
until	 a	 particular	 enzyme,	 PSA,	 removes	 the	
semenogelin	protein.	After	 the	enzyme	removes	
this	protein,	the	sperm	can	swim	toward	the	egg.16
The	MCI	discourse,	 thus,	 (re)produces	 lay	and	
scientific	conceptions	that	present	both	male	and	
female	bodies,	more	specifically	the	gametes	of	both,	
based	on	gender	stereotypes	widely	disseminated	
16	MALE	CONTRACEPTION	INITIATIVE.	Emphasis	added.	Available	at:	<https://www.malecontraceptive.org>.	Accessed	on:	8	July,	2018.
in	our	society.	The	force	of	 industrial	production	
metaphors	used	to	explain	the	reproductive	systems	
is	 also	 explicit;	 such	metaphors	are	 constantly	
found	 in	 the	reports	of	MCI	aimed	at	explaining	
the	 functioning	of	 technologies	or	 the	notion	of	
physiological	difficulty.	The	use	of	the	expressions	
“sperm	production”	and	“egg	production”	is	almost	
a	rule	when	it	comes	to	these	topics.
Two sexes, two contraceptions
The	analysis	of	 the	physiological	difficulty	 in	
the	MCI	discourse	brings	to	the	fore	the	question	
of	 gender	 permeating	 scientific	 production,	 a	
central	debate	for	gender	and	science	studies.	What	
nature,	what	physiology,	what	bodies	are	these	that	
are	explanatory	of	 the	difficulty	 in	producing	a	
reversible	contraceptive	for	men?
Since	the	end	of	the	1980s,	the	conception	that	
sex	and	nature	are	given	elements,	prior	to	culture,	
has	been	questioned	 (Piscitelli,	 2009).	 In	Bodies 
That Matter,	the	philosopher	Judith	Butler	(1993),	
central	 to	 this	debate,	 states	 that	 it	 is	necessary	
to	return	to	the	materiality	of	bodies.	However,	in	
attempting	to	apprehend	the	body	as	something	
prior	to	socialization,	prior	to	distinct	discourses	on	
males	and	females,	we	“discover	that	matter	is	fully	
sedimented	with	discourses	on	sex	and	sexuality	
that	prefigure	and	constrain	the	uses	to	which	that	
term	can	be	put”	(Butler,	1993,	p.29).	In	this	context,	
there	was	an	effort	to	situate	historically	and	socially	
the	emergence	of	the	contemporary	understanding	
of	sexual	dimorphism,	that	is,	the	existence	of	two	
biological	sexes,	one	male	and	 the	other	 female.	
The	work	of	Laqueur	 (2001)	 is	exemplary	of	 this	
perspective.	In	the	eighteenth	century,	this	author	
describes	the	invention	of	sex	–	or,	more	specifically,	
the	emergence	of	 the	“two	sex	models,”	which	 is	
based	on	the	existence	of	two	bodies	with	opposite,	
stable	and	incommensurable	biological	sexes:	man	
body/woman	body.
This	perspective	of	radical	dissimilarity	between	
the	sexes,	which	places	the	differences	between	men	
and	women	in	the	body,	has	replaced	the	“single	sex	
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model”	that	has	prevailed	for	thousands	of	years.	
“Single	 sex”	because	until	 then	bodies	differed	
only	in	degree	and	levels	of	perfection,	a	hierarchy	
between	inverted	symmetries.	Both	had	the	same	
genitalia,	 except	 that	 in	men	 the	genitalia	was	
on	the	outside	of	the	body,	while	in	women	it	was	
inverted,	inside.	Based	on	a	hierarchy	that	placed	
the	body	of	men	as	the	model,	as	the	most	perfect,	
there	was	differentiation	 in	 the	amount	of	body	
heat	that	was	associated	with	this	exteriorization	
or	internalization	of	the	genitalia.	Such	a	difference	
did	not	characterize	the	existence	of	two	radically	
distinct	and	opposing	entities,	man	body/woman	
body;	and	it	was	even	less	the	basis	for	the	conception	
of	what	a	woman	was	and	what	a	man	was.	Thus	
men	and	women	had	in	one	sense	a	single	body	with	
only	a	difference	in	the	degree	of	perfection	–	even	
their	reproductive	organs	received	the	same	name	
in	many	contexts.	However,	in	no	way	women	were	
conceived	as	 socially	equal	 to	men;	 the	point	 is	
that	the	difference	was	not	in	the	body	but	in	social	
issues.	On	the	single	sex	model,	Laqueur	(2001,	p.19,	
emphasis	added)	states:
To	be	male	or	 female	was	 to	maintain	a	 social	
position,	a	place	in	society,	to	assume	a	cultural	
role,	not	to	be	organically	one	or	the	other	of	two	
incommensurable	sexes.	In	other	words,	sex	before	
the	seventeenth	century	was	still	a	sociological	
rather	than	ontological	category.
This	author	demonstrates	 that	 the	shift	 from	
the	single	sex	model	to	the	two-sex	model	cannot	
be	explained	just	by	the	scientific	progress,	by	the	
“discovery”	of	bodily	differences	between	men	and	
women.	He	states	that	before	the	notion	of	sexual	
dimorphism	became	dominant	 there	was	already	
technical	evidence	of	sexual	differences.	On	the	other	
hand,	he	also	points	to	other	evidence	consonant	with	
the	“single	sex	model”	contemporaneous	with	the	
diffusion	and	consolidation	of	the	model	of	the	two	
sexes	–	for	example,	the	conception	of	the	common	
origin	of	 the	 two	sexes	 from	a	morphologically	
androgynous	embryo	 in	 the	nineteenth	century.	
Thus,	the	invention	of	sex,	with	the	passage	from	
the	single	sex	to	the	model	of	the	two	sexes,	can	only	
be	understood	in	the	context	of	epistemological	and	
socio-cultural	changes,	especially	transformations	
in	gender	politics.	In	this	context,	especially	from	
the	nineteenth	 century	onwards,	 scientists	and	
physicians	endeavored	to	prove	that	men	and	women	
were	radically	different,	and	that	such	differences	
could	be	 found	beyond	sexual	and	 reproductive	
organs	and	functions.	Tramontano	(2017)	points	out	
that	the	anatomical	justification	for	this	model	of	
sexual	dimorphism	varied	throughout	history;	he	
underscores	that	the	question	of	where	specifically	
the	difference	between	men	and	women	is	found	has	
already	been	answered	in	a	number	of	ways:	in	the	
gonads,	the	muscles	and	the	nerves,	and	the	brain.	
However,	he	argues	that	in	hormones	is	the	answer	
that	holds	true	as	of	today.
Final considerations 
We	 believe	 that	 the	 explanation	 of	 the	
physiological	difficult	 to	answer	why	we	still	do	
not	have	a	male	contraceptive	equivalent	 to	 the	
birth	control	pill	can	be	put	 in	the	context	of	the	
biomedical	knowledge	that	emphasizes	differences	
between	men	and	women,	not	similarities.	Although	
there	are	dissenting	voices	 in	 the	 field	of	male	
contraception	 regarding	 the	 supposed	higher	
difficulty	 of	 interfering	with	 spermatogenesis	
compared	with	the	ease	of	interfering	with	ovulation,	
what	prevails	and	is	disclosed	to	the	lay	public	is	
the	notion	that	male	bodies	are	more	resistant	to	
contraception	because	their	reproductive	processes	
are	different	from	the	female	one,	a	conception	that	
agrees	with	the	model	of	two	sexes.
Male	bodies	are	understood	as	radically	distinct	
from	female	bodies	not	only,	but	mainly,	in	terms	of	
sexuality	and	reproduction.	Following	Oudshoorn	
(2003)	and	Martin	(1991),	one	wonders	what	would	
be	the	risks	and	possible	consequences	of	biological	
interpretations	based	on	homologous	descriptions	
of	sexual	and	reproductive	processes	in	the	bodies	
of	men	and	women.	Such	homologous	descriptions	
and	 conceptions	 of	 organisms	 could	 result	 in	
approaches	and	biomedical	interventions	that	are	
more	symmetrical,	which	would	differ	a	 lot	 from	
current	standards,	 in	which	 the	process	of	 (bio)
medicalization	affect	them	unevenly.	What	is	(bio)
medicalized	in	male	bodies?	And	in	female	bodies?
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Besides	 being	 different,	 such	 bodies	 are	
understood	as	being	more	amenable	to	biomedical	
interventions	in	certain	phenomena,	as	if	a	division	
of	 labor	 or	 a	 propensity	 for	 certain	 activities	
materializes	 in	 the	organisms.	Male	bodies	are	
complex	for	contraceptive	interventions,	but	they	
are	not	 for	 interventions	 in	 sexuality,	whereas	
in	female	bodies	the	opposite	is	true.	That	is,	the	
association	between	women	and	 reproduction/
contraception	and	between	men	and	sexuality	would	
be	inscribed	in	the	very	“nature”	of	their	bodies.	The	
promotion	of	a	“male	pill”	by	MCI,	with	its	proposal	
for	a	non-hormonal	paradigm	of	male	contraception,	
reinforces	the	conception	of	such	bodies	as	naturally	
complex	for	hormonal	contraception,	in	contrast	to	
female	bodies.	It	is	based	on	a	“natural”	motive	to	
justify	why	the	path	taken	for	intervention	in	the	
fertility	of	women	since	the	1960s,	although	highly	
criticized,	has	not	been	successful	in	men.
MCI,	 thus,	 tries	 to	 break	with	gender	 roles	
materialized	 in	 contraceptive	 technologies:	
contraception	is	a	woman’s	responsibility	and	women’s	
bodies	are	the	place	par	excellence	for	contraceptive	
interventions.	On	the	other	hand,	such	a	rupture	is	
built	without	confronting	the	radical	dissimilarity	
between	male	and	female	bodies	proposed	by	the	
two-sex	model,	a	bastion	for	the	gender	politics	of	
modernity.	According	to	the	NGO,	men	want	and	have	
the	right	to	have	access	to	reversible	and	effective	
contraceptive	technologies,	which	we	do	not	have	until	
today	mainly	due	to	lack	of	investment	in	methods	that	
can	overcome	the	physiological	difficulties	presented	
by	male	bodies	to	hormonal	modes	of	contraception,	
modes	that	are	effective	in	women’s	bodies.
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